1-6 of 6
factor ix
Close
Sort by
Journal Articles

Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors

Paul E. Monahan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 33–40.
https://doi.org/10.1182/asheducation-2015.1.33
Published: 2015
Journal Articles

Risky business of inhibitors: HLA haplotypes, gene polymorphisms, and immune responses

Birgit M. Reipert
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 372–378.
https://doi.org/10.1182/asheducation.V2014.1.372.3884771
Published: 2014
Journal Articles

Lasting power of new clotting proteins

Jerry S. Powell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 355–363.
https://doi.org/10.1182/asheducation-2014.1.355
Published: 2014
Journal Articles

Biological Rationale for New Drugs in the Bleeding Disorders Pipeline

Patrick F. Fogarty
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 397–404.
https://doi.org/10.1182/asheducation-2011.1.397
Published: 2011
Journal Articles

New Perspectives in Hemophilia Treatment

Craig M. Kessler
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 429–435.
https://doi.org/10.1182/asheducation-2005.1.429
Published: 2005
Journal Articles

Congenital Bleeding Disorders

Margaret E. Rick, Christopher E. Walsh, Nigel S. Key
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 559–574.
https://doi.org/10.1182/asheducation-2003.1.559
Published: 2003